Phio Pharmaceuticals Corp.·4

Feb 17, 6:30 PM ET

Kontulis Caitlin 4

4 · Phio Pharmaceuticals Corp. · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
Kontulis Caitlin
Secretary & Controller
Transactions
  • Tax Payment

    Common stock, $0.0001 par value

    2023-02-15$5.20/sh657$3,4167,994 total
Footnotes (2)
  • [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
  • [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION